SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-033503
Filing Date
2010-06-11
Accepted
2010-06-11 16:30:34
Documents
5
Period of Report
2010-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-11869_18k.htm 8-K 136993
2 EX-3.1 a10-11869_1ex3d1.htm EX-3.1 122881
3 EX-10.1 a10-11869_1ex10d1.htm EX-10.1 139269
4 EX-10.2 a10-11869_1ex10d2.htm EX-10.2 63824
5 EX-10.3 a10-11869_1ex10d3.htm EX-10.3 59486
  Complete submission text file 0001104659-10-033503.txt   524361
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 10892847
SIC: 2836 Biological Products, (No Diagnostic Substances)